News

Eyestem will be presenting its data at the ARVO 2025 Annual Meeting as well as the 10th Retinal Cell and Gene Therapy ...
Eyestem Research, a Bangalore-based cell therapy company, is pleased to announce significant vision improvement in Phase 1 trials of its investigational drug, Eyecyte-RPEtm, in patients with ...
An eye check up is more than just about finding vision issues. A thorough eye or retinal scan can, in fact, reveal early signs of hypertension, diabetes, cardiovascular issues and Alzheimer's ...
Dr Jay Goyal highlights the social, biological, and structural barriers preventing women from accessing timely eye care, and ...
Question: I recently wore a sleep mask that was a little tight and ever since, my vision has been a little blurry when ...
The global chronic ocular pain market, valued at US$ 7.19 billion in 2023, is poised for substantial growth, with a projected market valuation of US$ 12.44 billion by 2032. This growth is driven by an ...
Annexon achieved primary endpoints in two Phase 3 studies for tanruprubart in treating Guillain-Barre Syndrome, setting the stage for a pre-BLA meeting ...
Heatwaves pose a significant risk to eye health, increasing the likelihood of eye strokes due to dehydration and thickened ...
They say the eyes are the mirror of the soul... but it turns out they are also the mirror of your body! Sometimes, before you ...
The wet form of age-related macular ... degeneration can start suddenly. You won’t feel pain, but you might notice vision problems. If you’re having vision problems or have been diagnosed with ...
Eyestem Research announced positive results from its phase 1 trial ( NCT06394232) evaluating its investigational drug product ...